TY - JOUR
T1 - Risk of cancer among relatives of patients with glioma
AU - O’Neill, Brian P.
AU - Blondal, Hannes
AU - Yang, Ping
AU - Olafsdottir, Gurri H.
AU - Sigvaldason, H.
AU - Jenkins, Robert B.
AU - Kimmel, David W.
AU - Scheithauer, Bernd W.
AU - Rocca, Walter A.
AU - Bjornsson, Johannes
AU - Tulinius, Hfran
PY - 2002/9
Y1 - 2002/9
N2 - We report a population-based, retrospective study of 396 Icelandic people diagnosed with glioma in the years 1940-1995. The purpose of this study was to test whether astrocytomas, other glial tumors, other central nervous system tumors, or other cancers aggregate in families identified through glioma probands who were of Icelandic origin. Pedigrees of the 396 cases were traced by the Genetical Committee of the University of Iceland and linked to the Icelandic Cancer Registry. A total of 25, 546 relatives, including 2, 080 individuals with cancer were identified within these pedigrees. There was no statistically significant increase of glioma in relatives of glioma patients, nor was there any statistically significant increase in risk for other central nervous system tumors. There was no overall increase in incidence of all cancer combined, nor of specific common cancers (lung, prostate, breast, stomach, and colorectal) and uncommon cancers (melanoma and pancreas) in the relatives of glioma patients. Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene.
AB - We report a population-based, retrospective study of 396 Icelandic people diagnosed with glioma in the years 1940-1995. The purpose of this study was to test whether astrocytomas, other glial tumors, other central nervous system tumors, or other cancers aggregate in families identified through glioma probands who were of Icelandic origin. Pedigrees of the 396 cases were traced by the Genetical Committee of the University of Iceland and linked to the Icelandic Cancer Registry. A total of 25, 546 relatives, including 2, 080 individuals with cancer were identified within these pedigrees. There was no statistically significant increase of glioma in relatives of glioma patients, nor was there any statistically significant increase in risk for other central nervous system tumors. There was no overall increase in incidence of all cancer combined, nor of specific common cancers (lung, prostate, breast, stomach, and colorectal) and uncommon cancers (melanoma and pancreas) in the relatives of glioma patients. Our results do not support the hypothesis of a familial aggregation of glioma indicative of a glioma susceptibility gene.
UR - http://www.scopus.com/inward/record.url?scp=0036715339&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036715339&partnerID=8YFLogxK
M3 - Article
C2 - 12223439
AN - SCOPUS:0036715339
SN - 1055-9965
VL - 11
SP - 921
EP - 924
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 9
ER -